|
Volumn 28, Issue 4, 1996, Pages 2159-2161
|
Are cytochrome P450 3A enzymes in the small intestine responsible for different cyclosporine metabolite patterns in stable male and female renal allograft recipients after co-administration of diltiazem?
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCIUM CHANNEL BLOCKING AGENT;
CYCLOSPORIN A;
CYTOCHROME P450;
DILTIAZEM;
ENZYME INHIBITOR;
IMMUNOSUPPRESSIVE AGENT;
ADULT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPETITIVE INHIBITION;
CONFERENCE PAPER;
CROSSOVER PROCEDURE;
DRUG BIOAVAILABILITY;
DRUG FORMULATION;
DRUG METABOLISM;
EMULSION;
ENZYME ACTIVITY;
FEMALE;
GRAFT REJECTION;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INTESTINE EPITHELIUM CELL;
KIDNEY ALLOGRAFT;
KIDNEY TRANSPLANTATION;
MALE;
NEPHROTOXICITY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
SMALL INTESTINE;
ADOLESCENT;
ADULT;
AGED;
CALCIUM CHANNEL BLOCKERS;
CYCLOSPORINE;
CYTOCHROME P-450 CYP2E1;
CYTOCHROME P-450 ENZYME SYSTEM;
DILTIAZEM;
DUODENUM;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INTESTINAL MUCOSA;
KIDNEY TRANSPLANTATION;
MALE;
METABOLIC CLEARANCE RATE;
MICROSOMES;
MIDDLE AGED;
MIXED FUNCTION OXYGENASES;
SEX CHARACTERISTICS;
|
EID: 0029788148
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (22)
|
References (0)
|